CTLT
Price
$55.83
Change
-$0.47 (-0.83%)
Updated
Apr 30, 6:59 PM EST
118 days until earnings call
LFCR
Price
$6.42
Change
-$0.04 (-0.62%)
Updated
Apr 30, 6:59 PM EST
91 days until earnings call
Ad is loading...

CTLT vs LFCR ᐉ Comparison: Which is Better to Invest?

Header iconCTLT vs LFCR Comparison
Open Charts CTLT vs LFCRBanner chart's image
CATALENT
Price$55.83
Change-$0.47 (-0.83%)
Volume$650.96K
CapitalizationN/A
Lifecore Biomedical
Price$6.42
Change-$0.04 (-0.62%)
Volume$63.9K
CapitalizationN/A
View a ticker or compare two or three
CTLT vs LFCR Comparison Chart

Loading...

CTLTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LFCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CTLT vs. LFCR commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTLT is a Hold and LFCR is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (CTLT: $56.30 vs. LFCR: $6.46)
Brand notoriety: CTLT and LFCR are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CTLT: 75% vs. LFCR: 32%
Market capitalization -- CTLT: $10.19B vs. LFCR: $176.87M
CTLT [@Pharmaceuticals: Other] is valued at $10.19B. LFCR’s [@Pharmaceuticals: Other] market capitalization is $176.87M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTLT’s FA Score shows that 1 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • CTLT’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTLT and LFCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTLT’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 5 bullish TA indicator(s).

  • CTLT’s TA Score: 4 bullish, 5 bearish.
  • LFCR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than CTLT.

Price Growth

CTLT (@Pharmaceuticals: Other) experienced а +0.45% price change this week, while LFCR (@Pharmaceuticals: Other) price change was +2.70% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.81%. For the same industry, the average monthly price growth was +28.38%, and the average quarterly price growth was +18975.91%.

Reported Earning Dates

CTLT is expected to report earnings on Aug 27, 2024.

LFCR is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+1.81% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
A.I.dvisor published
a Summary for CTLT with price predictions.
OPEN
A.I.dvisor published
a Summary for LFCR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CTLT($10.2B) has a higher market cap than LFCR($177M). CTLT YTD gains are higher at: 25.306 vs. LFCR (4.362). LFCR has higher annual earnings (EBITDA): -22.64M vs. CTLT (-754M). CTLT has more cash in the bank: 229M vs. LFCR (4.22M). LFCR has less debt than CTLT: LFCR (157M) vs CTLT (5.01B). CTLT has higher revenues than LFCR: CTLT (4.1B) vs LFCR (188M).
CTLTLFCRCTLT / LFCR
Capitalization10.2B177M5,763%
EBITDA-754M-22.64M3,331%
Gain YTD25.3064.362580%
P/E Ratio208.33N/A-
Revenue4.1B188M2,180%
Total Cash229M4.22M5,424%
Total Debt5.01B157M3,194%
FUNDAMENTALS RATINGS
CTLT vs LFCR: Fundamental Ratings
CTLT
LFCR
OUTLOOK RATING
1..100
6678
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
4042
P/E GROWTH RATING
1..100
31
SEASONALITY SCORE
1..100
n/a65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTLT's Valuation (95) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CTLT’s stock grew similarly to LFCR’s over the last 12 months.

CTLT's Profit vs Risk Rating (78) in the Pharmaceuticals Other industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that CTLT’s stock grew similarly to LFCR’s over the last 12 months.

CTLT's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as LFCR (97) in the Industrial Specialties industry. This means that CTLT’s stock grew similarly to LFCR’s over the last 12 months.

CTLT's Price Growth Rating (40) in the Pharmaceuticals Other industry is in the same range as LFCR (42) in the Industrial Specialties industry. This means that CTLT’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (1) in the Industrial Specialties industry is in the same range as CTLT (3) in the Pharmaceuticals Other industry. This means that LFCR’s stock grew similarly to CTLT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTLTLFCR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
68%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 15 days ago
72%
Declines
ODDS (%)
Bearish Trend 6 days ago
69%
Bearish Trend 2 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CTLTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LFCRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GXTG23.370.51
+2.23%
Global X Thematic Growth ETF
SMMD62.390.45
+0.73%
iShares Russell 2500 ETF
IEFA72.740.38
+0.53%
iShares Core MSCI EAFE ETF
APRT34.370.13
+0.37%
AllianzIM US Large Cap Buffer10 Apr ETF
VFMF122.480.42
+0.34%
Vanguard US Multifactor ETF

CTLT and

Correlation & Price change

A.I.dvisor tells us that CTLT and ELAN have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTLT and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTLT
1D Price
Change %
CTLT100%
+0.68%
ELAN - CTLT
28%
Poorly correlated
+2.34%
ESPR - CTLT
26%
Poorly correlated
+4.74%
ALVO - CTLT
26%
Poorly correlated
+0.49%
FLGC - CTLT
25%
Poorly correlated
-5.88%
LFCR - CTLT
23%
Poorly correlated
-2.05%
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-2.05%
SHPH - LFCR
31%
Poorly correlated
+1.89%
CRON - LFCR
29%
Poorly correlated
-1.54%
CGC - LFCR
28%
Poorly correlated
-6.62%
TLRY - LFCR
27%
Poorly correlated
-0.56%
OGI - LFCR
26%
Poorly correlated
+0.54%
More